MOLTENI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.992
EU - Europa 1.870
AS - Asia 828
SA - Sud America 52
AF - Africa 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.753
Nazione #
US - Stati Uniti d'America 2.951
IT - Italia 652
DE - Germania 362
SG - Singapore 347
CN - Cina 182
IE - Irlanda 167
SE - Svezia 138
RU - Federazione Russa 117
AT - Austria 87
HK - Hong Kong 87
GB - Regno Unito 79
ID - Indonesia 66
BR - Brasile 48
UA - Ucraina 47
IN - India 46
FI - Finlandia 41
VN - Vietnam 41
CA - Canada 40
DK - Danimarca 30
ES - Italia 29
BE - Belgio 28
FR - Francia 26
PL - Polonia 16
KR - Corea 14
CH - Svizzera 12
JP - Giappone 12
NL - Olanda 11
TR - Turchia 11
CZ - Repubblica Ceca 8
IR - Iran 6
RO - Romania 6
TW - Taiwan 6
BG - Bulgaria 5
EG - Egitto 5
EE - Estonia 3
NZ - Nuova Zelanda 3
AR - Argentina 2
HU - Ungheria 2
MY - Malesia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
EC - Ecuador 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
LT - Lituania 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 5.753
Città #
Ann Arbor 1.022
Frankfurt am Main 296
Chandler 254
Singapore 254
Wilmington 209
Milan 184
Dublin 162
Woodbridge 161
Fairfield 144
Ashburn 98
Hong Kong 86
Dearborn 83
New York 81
Vienna 81
Houston 73
Seattle 65
Jakarta 64
Princeton 58
Santa Clara 55
Cambridge 51
Jacksonville 43
Nanjing 32
Helsinki 30
Rome 30
Shanghai 30
London 28
Brussels 25
Granada 24
Council Bluffs 23
Pune 23
Fremont 18
Lawrence 17
Nuremberg 16
Guangzhou 15
Los Angeles 15
Altamura 14
Monza 13
Romola 13
Toronto 12
San Diego 11
Andover 10
Boardman 10
Carate Brianza 10
Beijing 9
Kunming 9
Nanchang 9
Tokyo 9
Dong Ket 8
Hangzhou 8
Hebei 8
Lachine 8
Sacramento 8
Edmonton 7
Shenyang 7
Bari 6
Chiavari 6
Falls Church 6
Melzo 6
Munich 6
Radomsko 6
Turin 6
Arcore 5
Bergamo 5
Bresso 5
Brno 5
Chicago 5
Durham 5
Kiev 5
Napoli 5
Pavia 5
São Paulo 5
Tampa 5
Zurich 5
Assago 4
Bolzano 4
Bonndorf 4
Cagliari 4
Como 4
Jinan 4
Lecco 4
Norwalk 4
Ottawa 4
Padova 4
Piemonte 4
Plovdiv 4
Ropczyce 4
Seregno 4
Taizhou 4
Thunder Bay 4
Tianjin 4
Ancona 3
Auburn 3
Auckland 3
Bodio Lomnago 3
Brescia 3
Cardito 3
Carobbio degli Angeli 3
Changsha 3
Cologno 3
Cormano 3
Totale 4.233
Nome #
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 368
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 354
Growth hormone secretagogues and the regulation of calcium signaling in muscle 331
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 322
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 295
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 285
PHARMACOLOGICAL CHARACTERIZATION OF THE INTRACELLULAR SIGNALLING PATHWAY ACTIVATED BY TLQP-21 264
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 259
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 243
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 237
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 223
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 214
Parma consensus statement on metabolic disruptors 207
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 196
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 191
TLQP-21 modulate inflammation and fibrosis in a model of ards 188
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 155
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 145
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 140
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 139
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 138
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 137
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 131
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 111
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 102
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 98
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 78
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 77
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 69
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 62
The Role of NMNAT2/SARM1 in Neuropathy Development 58
null 57
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 57
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 41
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 33
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 32
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 24
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 21
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 19
Role of nutrition in degenerative disease 6
Totale 6.107
Categoria #
all - tutte 21.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 0 0 0 0 0 70 53 22
2020/20211.008 42 43 97 97 72 101 83 90 87 85 99 112
2021/2022656 91 71 56 52 37 44 22 21 24 58 58 122
2022/20231.122 130 252 140 116 56 172 21 79 75 17 33 31
2023/2024726 26 39 41 53 76 202 121 28 42 13 14 71
2024/20251.126 96 132 119 121 158 120 167 62 131 20 0 0
Totale 6.107